DEA Adds Benzimidazole-Opioids to Schedule I Drug List

The Drug Enforcement Administration is permanently placing the synthetic benzimidazole-opioids etodesnitazene, n-pyrrolidino etonitazene and protonitazene in Schedule I of the Controlled Substances Act, it said in a final order released April 10. The substances had already been temporarily listed in Schedule I since 2022 (see 2204110029). The final order is set to take effect April 11.